Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study
Journal
-
- The Lancet Oncology
-
The Lancet Oncology 22 (6), 765-778, 2021-06
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360294646505102080
-
- ISSN
- 14702045
-
- Data Source
-
- Crossref